𝔖 Bobbio Scriptorium
✦   LIBER   ✦

BRCA2 mutation in a family with hereditary prostate cancer

✍ Scribed by Henrik Grönberg; Anna-Karin Åhman; Monica Emanuelsson; Anders Bergh; Jan-Erik Damber; Åke Borg

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
71 KB
Volume
30
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

BRCA2 germline mutations in Japanese bre
BRCA2 germline mutations in Japanese breast cancer families
✍ Rie Inoue; Toshikazu Ushijima; Takashi Fukutomi; Atsuo Fukami; Haruhiko Sugimura 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 125 KB 👁 2 views

Germline mutations of BRCA2 were examined in 20 Japanese breast cancer families without BRCA1 mutations, including one demonstrating cancer development in a male. Three different mutations, resulting in truncation of the BRCA2 protein, were detected in 3 different families. They were 9474insA (exon

No evidence for a role ofBRCA1 orBRCA2 m
No evidence for a role ofBRCA1 orBRCA2 mutations in Ashkenazi Jewish families with hereditary prostate cancer
✍ Wilkens, Eric P.; Freije, Diha; Xu, Jianfeng; Nusskern, Deborah R.; Suzuki, Hiro 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB 👁 2 views

## BACKGROUND. Two genes responsible for hereditary breast cancer (BRCA1 and BRCA2) have been identified, and predisposing mutations identified. Several studies have provided evidence that germline mutations in BRCA1 and BRCA2 confer an increased risk of prostate cancer. Based on these findings, o

Common mutations in BRCA1 and BRCA2 do n
Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men
✍ Nastiuk, Kent L.; Mansukhani, Mahesh; Terry, Mary Beth; Kularatne, Piyumika; Rub 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 262 KB 👁 1 views

BACKGROUND. Families with a high incidence of hereditary breast cancer, and subsequently shown to have terminating mutations in BRCA1 or BRCA2, appear to have a higher incidence of prostate cancer among male relatives. We aimed to determine whether the common germline mutations of BRCA1 or BRCA2 in